NRx Pharmaceuticals, Inc. (NRXP) Social Stream
NRX PHARMACEUTICALS INC (NRXP) Price Targets From Analysts
Use the tables below to see what analysts covering NRX PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-06-30 | 1 | $2 | $2 | $2 | $0.46 | 334.78% |
| 2023-02-02 | 2 | $4 | $2 | $3 | $0.46 | 552.17% |
| 2023-03-17 | 3 | $4 | $2 | $3 | $0.46 | 552.17% |
| 2023-05-25 | 3 | $9 | $2 | $5 | $0.46 | 986.96% |
| 2023-08-07 | 3 | $4 | $0.35 | $2.116 | $0.46 | 360% |
| 2023-08-15 | 3 | $4 | $0.33 | $2.11 | $0.46 | 358.7% |
| 2023-10-24 | 3 | $4 | $2 | $2.666 | $0.46 | 479.57% |
| 2023-11-06 | 3 | $5 | $2 | $3 | $0.46 | 552.17% |
The Trend in the Analyst Price Target
Over the past 165 days, NRXP's average price target has gone down $2.
NRXP reports an average of 600.77% for its upside potential over the past 40 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-17 | 3 | 4 | 2.00 | 3.000 | 0.710 | 322.54% |
| 2023-08-15 | 3 | 4 | 0.33 | 2.110 | 0.340 | 520.59% |
| 2023-09-07 | 3 | 4 | 2.00 | 2.666 | 0.245 | 988.16% |
| 2023-10-24 | 3 | 4 | 2.00 | 2.666 | 0.278 | 858.99% |
| 2023-11-06 | 3 | 5 | 2.00 | 3.000 | 0.345 | 769.57% |
NRXP Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.33 | 2 | 1 | 0 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
NRXP's average broker recommendation rating worsened by 0.33 over the prior 17 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, NRX PHARMACEUTICALS INC's average analyst price target is greater than 13.26% of them.
- To contextualize these metrics, consider that out of all US stocks, NRX PHARMACEUTICALS INC's number of analysts covering the stock is higher than 49.94% of them.
- NRX PHARMACEUTICALS INC's variance in analysts' estimates is lower than -481.89% of stocks in the small market cap category.
- To contextualize these metrics, consider that out of stocks in the small market cap category, NRX PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 740.2% of them.
Stocks similar to NRX PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are NCNA, ATNF, and CTXR.
View All Top Stocks by Price Target
What is the outlook for NRXP? Use POWR Ratings for clearer insight into price direction.